1.
Inherited Platelet Disorders -- Handin 2005 (1): 396 -- Hematology
The inherited platelet disorders are a heterogeneous collection of rare diseases ..... Primary pulmonary hypertension in a patient with a familial platelet ...
2.
Congenital and Acquired Thrombocytopenia -- Cines et al. 2004 (1 ...
There are two partially overlapping forms of familial thrombocytopenia: those with microcytic anemia, i.e., the XLT-T syndrome (X-linked thrombocytopenia– ...
3.
About the Hematology ASH Education Book
Michael L. Linenberger, MD (2008–2011) Sagar Lonial, MD (2007–2010) Charles T. Quinn, MD (2008–2009) Jacob M. Rowe, MD (2008–2009) Mikkael A. Sekeres, MD, ...
4.
Tumor-Specific Genetic Lesions and Their Influence on Therapy in ...
Efforts to define the genetic lesions that underlie ALL have identified a .... arrays precluded the clear identification of the target gene(s) affected by ...
5.
Defining and Managing Imatinib Resistance -- Mauro 2006 (1): 219 ...
This being said, imatinib does have its limitations; as much as it has taught us about the possibility of success based on rational drug design and ...
6.
Initial Therapy of Multiple Myeloma Patients Who Are Not ...
Multiple myeloma patients deemed to not be candidates for high-dose therapy .... Though MP has been one of the standards of care for older patients, ...
7.
Paroxysmal Nocturnal Hemoglobinuria: An Historical Overview ...
The clinical hallmark of paroxysmal nocturnal hemoglobinuria (PNH) is .... under these experimental conditions, hemoglobinuria and hemoglobinemia increased. ...
8.
Hodgkin's Lymphoma: Basing the Treatment on the Evidence ...
Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence. Leuk Lymphoma. 1997;26(3-4):359–68. ...
9.
Thrombocytosis and Thrombosis -- Vannucchi and Barbui 2007 (1 ...
[Abstract/Free Full Text]; Di Nisio M, Barbui T, Di Gennaro L, et al. ... [Abstract/Free Full Text]; Barbui T, Finazzi G. When and how to treat essential ...
10.
Molecular Signatures Define New Rational Treatment Targets in ...
In addition, the emerging molecular signatures of specific subtypes of LBCL may improve diagnostic accuracy and highlight potential rational treatment ...
